Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, May 24, 2024 | Back issues
Courthouse News Service Courthouse News Service

Kerri Yingst v. Novartis AG; Novartis Corp.; Novartis Consumer Health

Novartis charges a premium for Excedrin Migraine though it is "pharmacologically identical" to Excedrin Extra Strength, a class claims.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.